Spinnaker Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $295K | Hold |
2,310
| – | – | 0.02% | 254 |
|
|
2025
Q4 | $282K | Hold |
2,310
| – | – | 0.02% | 262 |
|
|
2025
Q3 | $231K | Buy |
+2,310
| New | +$208K | 0.01% | 277 |
|
|
2025
Q1 | – | Sell |
-2,499
| Closed | -$225K | – | 295 |
|
|
2024
Q4 | $225K | Hold |
2,499
| – | – | 0.01% | 266 |
|
|
2024
Q3 | $247K | Buy |
2,499
+24
| +1% | +$2.36K | 0.02% | 262 |
|
|
2024
Q2 | $229K | Hold |
2,475
| – | – | 0.01% | 258 |
|
|
2024
Q1 | $235K | Sell |
2,475
-304
| -11% | -$28.2K | 0.02% | 254 |
|
|
2023
Q4 | $248K | Hold |
2,779
| – | – | 0.02% | 249 |
|
|
2023
Q3 | $203K | Hold |
2,779
| – | – | 0.02% | 265 |
|
|
2023
Q2 | $231K | Hold |
2,779
| – | – | 0.02% | 243 |
|
|
2023
Q1 | $212K | Hold |
2,779
| – | – | 0.02% | 242 |
|
|
2022
Q4 | $231K | Sell |
2,779
-24
| -0.9% | -$1.94K | 0.02% | 247 |
|
|
2022
Q3 | $222K | Hold |
2,803
| – | – | 0.02% | 248 |
|
|
2022
Q2 | $208K | Hold |
2,803
| – | – | 0.02% | 260 |
|
|
2022
Q1 | $252K | Hold |
2,803
| – | – | 0.02% | 256 |
|
|
2021
Q4 | $314K | Hold |
2,803
| – | – | 0.02% | 233 |
|
|
2021
Q3 | $352K | Sell |
2,803
-24
| -0.8% | -$3.09K | 0.02% | 221 |
|
|
2021
Q2 | $383K | Hold |
2,827
| – | – | 0.03% | 214 |
|
|
2021
Q1 | $383K | Hold |
2,827
| – | – | 0.03% | 198 |
|
|
2020
Q4 | $397K | Hold |
2,827
| – | – | 0.03% | 182 |
|
|
2020
Q3 | $315K | Sell |
2,827
-393
| -12% | -$44.1K | 0.03% | 187 |
|
|
2020
Q2 | $360K | Hold |
3,220
| – | – | 0.03% | 179 |
|
|
2020
Q1 | $249K | Hold |
3,220
| – | – | 0.03% | 204 |
|
|
2019
Q4 | $306K | Hold |
3,220
| – | – | 0.03% | 211 |
|
|
2019
Q3 | $245K | Hold |
3,220
| – | – | 0.02% | 225 |
|
|
2019
Q2 | $282K | Sell |
3,220
-30
| -0.9% | -$2.56K | 0.03% | 200 |
|
|
2019
Q1 | $294K | Hold |
3,250
| – | – | 0.03% | 198 |
|
|
2018
Q4 | $233K | Hold |
3,250
| – | – | 0.03% | 203 |
|
|
2018
Q3 | $311K | Buy |
3,250
+778
| +31% | +$75.4K | 0.03% | 190 |
|
|
2018
Q2 | $235K | Hold |
2,472
| – | – | 0.03% | 198 |
|
|
2018
Q1 | $216K | Hold |
2,472
| – | – | 0.02% | 203 |
|
|
2017
Q4 | $209K | Sell |
2,472
-150
| -6% | -$12.6K | 0.02% | 206 |
|
|
2017
Q3 | $226K | Hold |
2,622
| – | – | 0.03% | 192 |
|
|
2017
Q2 | $202K | Sell |
2,622
-420
| -14% | -$29.8K | 0.03% | 195 |
|
|
2017
Q1 | $211K | Sell |
3,042
-492
| -14% | -$33K | 0.03% | 198 |
|
|
2016
Q4 | $209K | Hold |
3,534
| – | – | 0.03% | 187 |
|
|
2016
Q3 | $234K | Buy |
+3,534
| New | +$219K | 0.03% | 172 |
|
|
2016
Q1 | – | Sell |
-7,369
| Closed | -$517K | – | 209 |
|
|
2015
Q4 | $517K | Sell |
7,369
-18,181
| -71% | -$1.24M | 0.07% | 135 |
|
|
2015
Q3 | $1.59M | Sell |
25,550
-42,160
| -62% | -$3.32M | 0.24% | 75 |
|
|
2015
Q2 | $5.69M | Sell |
67,710
-648
| -0.9% | -$50.4K | 0.85% | 27 |
|
|
2015
Q1 | $5.14M | Sell |
68,358
-62,673
| -48% | -$4.38M | 0.74% | 29 |
|
|
2014
Q4 | $8.14M | Buy |
131,031
+1,059
| +0.8% | +$60.4K | 1.21% | 18 |
|
|
2014
Q3 | $6.76M | Buy |
129,972
+1,242
| +1% | +$63.3K | 1.09% | 22 |
|
|
2014
Q2 | $6.61M | Buy |
128,730
+6,084
| +5% | +$274K | 1.08% | 23 |
|
|
2014
Q1 | $5.83M | Sell |
122,646
-13,539
| -10% | -$693K | 0.96% | 27 |
|
|
2013
Q4 | $5.91M | Buy |
136,185
+885
| +0.7% | +$36.6K | 0.98% | 27 |
|
|
2013
Q3 | $5.83M | Buy |
135,300
+9,546
| +8% | +$387K | 1.06% | 26 |
|
|
2013
Q2 | $4.37M | Buy |
+125,754
| New | +$4.42M | 0.82% | 36 |
|
Other funds holding XBI
Spinnaker Trust's XBI Position: Q1 2026 in Review
Spinnaker Trust held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,310 shares worth $295K. The position accounts for 0.02% of the portfolio, ranked #254.
Spinnaker Trust first reported a position in XBI in Q2 2013 and has held it in 48 quarters since. The position peaked at $8.14M in Q4 2014. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Spinnaker Trust held 2,310 shares of State Street SPDR S&P Biotech ETF worth $295K as of Q1 2026.
- Spinnaker Trust left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of Spinnaker Trust's portfolio in Q1 2026, its #254 holding.
- Spinnaker Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 48 quarters since.
- Spinnaker Trust's State Street SPDR S&P Biotech ETF position peaked at $8.14M in Q4 2014.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.